LifeStance Health announced that Dr. Ujjwal Ramtekkar will join the company as Chief Medical Officer, effective January 22, 2024. He will lead all clinical services, ensuring that LifeStance's psychiatric and psychotherapy clinicians are enabled to deliver high-quality, personalized patient care that meets and exceeds professional standards. Dr. Ramtekkar is a double board-certified pediatric and adult psychiatrist.

He previously held senior clinical leadership roles at quarter Health and Teladoc Health. At both organizations, he was responsible for leading clinical strategy, expanding clinical services, optimizing clinical operations and creating high-impact initiatives for clinician engagement and clinical quality. Additionally, Dr. Ramtekkar is an adjunct clinical professor of psychiatry at University of Missouri-Columbia School of Medicine.

He completed his psychiatry residency training at Washington University School of Medicine in Saint Louis, where he was also trained in psychiatric epidemiology, as well as a fellowship in child and adolescent psychiatry at Harvard Medical School. He received an MBA from Maryville University. Dr. Ramtekkar replaces Dr. Anisha Patel-Dunn, who is stepping down to spend more time with her family.

Since joining the company in 2019, Dr. Patel-Dunn has played a critical role in establishing LifeStance as a clinical leader in outpatient mental health. Dr. Patel-Dunn will work closely with Dr. Ramtekkar to ensure a seamless transition.